Skip to content

Efficacy and Safety of Pegmolesatide, a Novel Treatment for Anemia in Patients with Chronic Kidney Disease

Anemia is a common complication in patients with chronic kidney disease (CKD), significantly lowering patients’ quality of life and increasing cardiovascular risks. Traditionally, recombinant erythropoietin (EPO), such as epoetin alfa, has been used to treat… Efficacy and Safety of Pegmolesatide, a Novel Treatment for Anemia in Patients with Chronic Kidney Disease

Effects and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: Insights from the GREAT-ASTRE Study

Recently, SGLT2 inhibitors (SGLT2i) have been proven to provide cardiovascular and renal protection for patients with chronic kidney disease (CKD), effectively slowing renal function decline and reducing proteinuria and blood pressure, regardless of diabetes status.… Effects and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients: Insights from the GREAT-ASTRE Study